FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:1317-1318 May 5, 1994 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Samuel, D.

To the Editor: Samuel et al. (Dec. 16 issue)¹ report the results of a major retrospective multicenter study of liver transplantation in European patients with hepatitis B virus (HBV) infection. Of great clinical importance is the observed reduction in the risk of recurrence of HBV in recipients of liver allografts who received long-term ( 6 months) passive immunoprophylaxis with anti-hepatitis B surface antigen; no benefit was seen with short-term (2 months) immunoprophylaxis.

The mean (±SE) length of time to HBV recurrence was 3.0 ±2.6 months in patients receiving short-term immunoprophylaxis, 3.2 ±2.7 in those not given immunoprophylaxis, and 8.6 ±6.8 . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.